Robert Betts
Concepts (474)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Influenza, Human | 42 | 1974 | 94 |
Why?
| Influenza Vaccines | 33 | 1974 | 70 |
Why?
| Influenza A virus | 41 | 1976 | 63 |
Why?
| Candidiasis | 8 | 1988 | 28 |
Why?
| Antifungal Agents | 7 | 2002 | 34 |
Why?
| Antibodies, Viral | 46 | 1974 | 104 |
Why?
| Cytomegalovirus Infections | 17 | 1965 | 39 |
Why?
| Echinocandins | 6 | 2002 | 4 |
Why?
| Herpes Zoster | 6 | 1975 | 17 |
Why?
| Influenza B virus | 5 | 1992 | 16 |
Why?
| Peptides, Cyclic | 4 | 2002 | 14 |
Why?
| Vaccines, Attenuated | 27 | 1976 | 22 |
Why?
| Neutropenia | 3 | 1998 | 42 |
Why?
| Antiviral Agents | 5 | 1991 | 91 |
Why?
| Double-Blind Method | 26 | 1977 | 274 |
Why?
| Adult | 79 | 1974 | 1317 |
Why?
| Kidney Transplantation | 16 | 1972 | 66 |
Why?
| Cytomegalovirus | 16 | 1972 | 42 |
Why?
| Respiratory Tract Infections | 7 | 1974 | 57 |
Why?
| Herpes Zoster Vaccine | 1 | 2007 | 3 |
Why?
| Pneumonia, Viral | 3 | 1991 | 17 |
Why?
| Fungemia | 4 | 2002 | 6 |
Why?
| Humans | 121 | 1972 | 1856 |
Why?
| Neuralgia, Postherpetic | 1 | 2007 | 8 |
Why?
| Aged | 32 | 1974 | 988 |
Why?
| Aspergillosis | 2 | 1988 | 18 |
Why?
| Middle Aged | 37 | 1972 | 1161 |
Why?
| Influenza A Virus, H1N1 Subtype | 11 | 1980 | 27 |
Why?
| Influenza A Virus, H3N2 Subtype | 9 | 1977 | 21 |
Why?
| Male | 55 | 1974 | 1553 |
Why?
| Vaccines, Synthetic | 8 | 1988 | 30 |
Why?
| Female | 51 | 1974 | 1643 |
Why?
| Rimantadine | 4 | 1981 | 7 |
Why?
| Aged, 80 and over | 11 | 1988 | 599 |
Why?
| Adamantane | 3 | 1988 | 6 |
Why?
| Adolescent | 30 | 1965 | 891 |
Why?
| Respiratory Syncytial Virus Infections | 3 | 1995 | 35 |
Why?
| Chickenpox | 2 | 1992 | 20 |
Why?
| Treatment Outcome | 9 | 1995 | 661 |
Why?
| Acyclovir | 2 | 1998 | 28 |
Why?
| Cold Temperature | 14 | 1972 | 59 |
Why?
| Nursing Homes | 5 | 1990 | 55 |
Why?
| Fever | 3 | 1977 | 65 |
Why?
| Piperacillin | 1 | 1998 | 6 |
Why?
| Viral Vaccines | 5 | 1977 | 35 |
Why?
| Ciprofloxacin | 1 | 1998 | 11 |
Why?
| Immunoglobulin G | 10 | 1974 | 191 |
Why?
| Vaccination | 8 | 1974 | 92 |
Why?
| Drug Therapy, Combination | 2 | 1997 | 189 |
Why?
| Vaccines, Inactivated | 5 | 1990 | 15 |
Why?
| Virus Diseases | 3 | 1980 | 50 |
Why?
| Disease Outbreaks | 3 | 1992 | 61 |
Why?
| Nasal Cavity | 2 | 1990 | 12 |
Why?
| Heart Transplantation | 3 | 1977 | 44 |
Why?
| Cross Infection | 5 | 1979 | 46 |
Why?
| Respirovirus Infections | 4 | 1980 | 22 |
Why?
| Amines | 2 | 1999 | 39 |
Why?
| Antibodies, Bacterial | 4 | 1986 | 50 |
Why?
| Toxoplasmosis | 1 | 1994 | 5 |
Why?
| Cryptococcosis | 1 | 1994 | 8 |
Why?
| Neuraminidase | 10 | 1976 | 12 |
Why?
| Amantadine | 3 | 1981 | 19 |
Why?
| Polysaccharides, Bacterial | 3 | 1986 | 33 |
Why?
| Aging | 3 | 1977 | 275 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 1994 | 41 |
Why?
| Administration, Intranasal | 9 | 1974 | 25 |
Why?
| Mycobacterium chelonae | 1 | 2012 | 7 |
Why?
| Ink | 1 | 2012 | 6 |
Why?
| Cosmetics | 1 | 2012 | 11 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2012 | 14 |
Why?
| Transplantation, Homologous | 10 | 1975 | 94 |
Why?
| Tattooing | 1 | 2012 | 8 |
Why?
| Pneumonia, Pneumocystis | 1 | 1994 | 28 |
Why?
| Body Fluids | 1 | 1992 | 21 |
Why?
| Complement System Proteins | 3 | 1980 | 30 |
Why?
| Hospitalization | 1 | 1995 | 169 |
Why?
| Amphotericin B | 4 | 1978 | 20 |
Why?
| Hemagglutinins, Viral | 7 | 1979 | 11 |
Why?
| Anti-Bacterial Agents | 4 | 1976 | 195 |
Why?
| Herpesvirus 3, Human | 4 | 1975 | 14 |
Why?
| Injections, Intramuscular | 6 | 1978 | 43 |
Why?
| Aspartate Aminotransferases | 3 | 1975 | 33 |
Why?
| Staphylococcal Vaccines | 1 | 2010 | 4 |
Why?
| Incidence | 3 | 1990 | 336 |
Why?
| Antigen-Antibody Complex | 2 | 1980 | 34 |
Why?
| Catheter-Related Infections | 1 | 2010 | 6 |
Why?
| Respiratory Syncytial Viruses | 3 | 1983 | 33 |
Why?
| Clinical Trials as Topic | 9 | 1975 | 251 |
Why?
| Recurrence | 5 | 1972 | 261 |
Why?
| Pain | 3 | 1975 | 191 |
Why?
| Phlebitis | 1 | 2009 | 4 |
Why?
| Cost of Illness | 2 | 2005 | 54 |
Why?
| Postoperative Complications | 7 | 1975 | 305 |
Why?
| Polymerase Chain Reaction | 1 | 1992 | 279 |
Why?
| Streptococcus pneumoniae | 2 | 1989 | 38 |
Why?
| Oxycodone | 1 | 2009 | 8 |
Why?
| Alkaline Phosphatase | 1 | 2009 | 59 |
Why?
| Delayed-Action Preparations | 1 | 2009 | 31 |
Why?
| Diphtheria Toxoid | 1 | 1989 | 14 |
Why?
| Neutralization Tests | 9 | 1965 | 37 |
Why?
| Young Adult | 2 | 2009 | 380 |
Why?
| Herpes Simplex | 2 | 1985 | 31 |
Why?
| Cyclohexanecarboxylic Acids | 1 | 2009 | 24 |
Why?
| Prospective Studies | 8 | 1975 | 545 |
Why?
| Orthomyxoviridae | 5 | 1976 | 34 |
Why?
| Immunocompromised Host | 2 | 2005 | 70 |
Why?
| Hemagglutination Inhibition Tests | 13 | 1976 | 28 |
Why?
| gamma-Aminobutyric Acid | 1 | 2009 | 58 |
Why?
| Seasons | 3 | 1989 | 64 |
Why?
| Seizures | 1 | 1989 | 79 |
Why?
| Enzyme-Linked Immunosorbent Assay | 5 | 1985 | 224 |
Why?
| Fluconazole | 1 | 2007 | 8 |
Why?
| New York | 9 | 1965 | 422 |
Why?
| Malacoplakia | 1 | 2007 | 7 |
Why?
| Rectal Diseases | 1 | 2007 | 13 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 125 |
Why?
| Hemagglutinin Glycoproteins, Influenza Virus | 3 | 1993 | 17 |
Why?
| Fibroblasts | 4 | 1975 | 179 |
Why?
| Lipoproteins | 1 | 2007 | 52 |
Why?
| Otitis Media | 1 | 1989 | 34 |
Why?
| Antigens, Viral | 4 | 1972 | 53 |
Why?
| Complement Fixation Tests | 5 | 1975 | 19 |
Why?
| Fluorescent Antibody Technique | 5 | 1972 | 164 |
Why?
| Antibody-Dependent Cell Cytotoxicity | 1 | 1985 | 14 |
Why?
| Comorbidity | 1 | 2007 | 190 |
Why?
| Ganciclovir | 1 | 2005 | 18 |
Why?
| Skin Diseases | 1 | 2007 | 69 |
Why?
| Chickenpox Vaccine | 1 | 2005 | 6 |
Why?
| Legionnaires' Disease | 1 | 2005 | 11 |
Why?
| Enzyme Inhibitors | 2 | 1996 | 216 |
Why?
| Antibodies, Anti-Idiotypic | 2 | 1981 | 35 |
Why?
| Immunoglobulin M | 3 | 1974 | 81 |
Why?
| Lymphokines | 1 | 1985 | 61 |
Why?
| Baculoviridae | 3 | 1996 | 23 |
Why?
| Killer Cells, Natural | 1 | 1985 | 62 |
Why?
| Neuralgia | 2 | 1982 | 13 |
Why?
| Immunoenzyme Techniques | 4 | 1984 | 125 |
Why?
| Time Factors | 9 | 1972 | 896 |
Why?
| Renal Dialysis | 2 | 1972 | 56 |
Why?
| Oligosaccharides | 3 | 1986 | 19 |
Why?
| Dose-Response Relationship, Drug | 5 | 1972 | 431 |
Why?
| Immunocompetence | 2 | 1998 | 15 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2004 | 15 |
Why?
| Gentamicins | 2 | 1984 | 32 |
Why?
| Personnel, Hospital | 3 | 1975 | 17 |
Why?
| Mycoses | 2 | 1982 | 22 |
Why?
| Child | 9 | 1965 | 749 |
Why?
| Homes for the Aged | 2 | 1992 | 25 |
Why?
| Bone Marrow Transplantation | 2 | 1977 | 90 |
Why?
| Microbial Sensitivity Tests | 3 | 1983 | 71 |
Why?
| Placebos | 5 | 1974 | 110 |
Why?
| Sequence Analysis, DNA | 2 | 1992 | 110 |
Why?
| Interferon Inducers | 3 | 1974 | 6 |
Why?
| Recombination, Genetic | 11 | 1976 | 78 |
Why?
| Respiration | 1 | 1982 | 78 |
Why?
| Bacterial Infections | 2 | 1982 | 88 |
Why?
| Cytotoxicity, Immunologic | 1 | 1981 | 54 |
Why?
| Peptides | 1 | 2002 | 154 |
Why?
| Cephalosporins | 2 | 1981 | 22 |
Why?
| Immunity, Mucosal | 1 | 2000 | 16 |
Why?
| Tissue Donors | 5 | 1975 | 41 |
Why?
| Kidney Failure, Chronic | 2 | 1972 | 57 |
Why?
| Safety | 1 | 2000 | 80 |
Why?
| Genes, Viral | 4 | 1978 | 37 |
Why?
| Simplexvirus | 2 | 1972 | 33 |
Why?
| Nasal Mucosa | 9 | 1974 | 22 |
Why?
| Hemagglutination Tests | 1 | 1998 | 13 |
Why?
| Mycobacterium bovis | 1 | 1998 | 7 |
Why?
| Mycobacterium Infections | 1 | 1998 | 11 |
Why?
| BCG Vaccine | 1 | 1998 | 22 |
Why?
| Vancomycin | 1 | 1998 | 23 |
Why?
| Cells, Cultured | 3 | 1972 | 447 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 1998 | 19 |
Why?
| Age Factors | 5 | 1976 | 480 |
Why?
| Osteomyelitis | 1 | 1998 | 39 |
Why?
| Cytarabine | 2 | 1975 | 32 |
Why?
| Infant | 6 | 1965 | 464 |
Why?
| Random Allocation | 5 | 1983 | 160 |
Why?
| Infant, Newborn | 4 | 1981 | 389 |
Why?
| Biopsy | 3 | 1972 | 207 |
Why?
| Bacterial Vaccines | 2 | 1986 | 27 |
Why?
| Cefotaxime | 1 | 1997 | 4 |
Why?
| Meningitis, Pneumococcal | 1 | 1997 | 8 |
Why?
| Haemophilus Vaccines | 2 | 1986 | 20 |
Why?
| Rheumatic Fever | 1 | 1977 | 9 |
Why?
| Temperature | 7 | 1976 | 137 |
Why?
| Retrospective Studies | 3 | 1978 | 653 |
Why?
| Immunologic Deficiency Syndromes | 1 | 1977 | 30 |
Why?
| Immunosuppression | 6 | 1977 | 47 |
Why?
| Rhinovirus | 2 | 1974 | 11 |
Why?
| Graft Rejection | 3 | 1977 | 59 |
Why?
| Interferons | 3 | 1974 | 39 |
Why?
| Picornaviridae Infections | 1 | 1995 | 9 |
Why?
| Urinary Bladder Neoplasms | 1 | 1998 | 44 |
Why?
| Sialic Acids | 1 | 1996 | 17 |
Why?
| Adaptation, Physiological | 2 | 1993 | 74 |
Why?
| APACHE | 2 | 2002 | 18 |
Why?
| Paramyxoviridae Infections | 1 | 1995 | 12 |
Why?
| Candida | 2 | 2002 | 19 |
Why?
| Community-Acquired Infections | 1 | 1995 | 17 |
Why?
| Graft Survival | 4 | 1978 | 74 |
Why?
| Pneumonia | 3 | 1977 | 85 |
Why?
| Infusions, Intravenous | 2 | 2002 | 87 |
Why?
| Hepatitis, Viral, Human | 3 | 1980 | 10 |
Why?
| Nausea | 2 | 1999 | 34 |
Why?
| Thiadiazoles | 1 | 1994 | 8 |
Why?
| Propylamines | 1 | 1974 | 4 |
Why?
| Nitriles | 1 | 1994 | 27 |
Why?
| DNA, Viral | 3 | 1972 | 98 |
Why?
| Follow-Up Studies | 3 | 1977 | 553 |
Why?
| Otitis Externa | 2 | 1976 | 1 |
Why?
| Common Cold | 2 | 1979 | 8 |
Why?
| Length of Stay | 1 | 1995 | 166 |
Why?
| Blood | 2 | 1972 | 67 |
Why?
| Blood Transfusion | 6 | 1975 | 59 |
Why?
| Animals | 12 | 1972 | 1031 |
Why?
| Immunoglobulin A | 3 | 1974 | 39 |
Why?
| Drug Resistance, Microbial | 3 | 1984 | 53 |
Why?
| Carrier Proteins | 2 | 1986 | 177 |
Why?
| HN Protein | 1 | 1993 | 10 |
Why?
| Viral Proteins | 2 | 1972 | 71 |
Why?
| Leukocyte Count | 3 | 1975 | 94 |
Why?
| Chickens | 1 | 1993 | 81 |
Why?
| Immunity, Innate | 2 | 1981 | 60 |
Why?
| Polyomavirus | 1 | 1972 | 9 |
Why?
| Chronic Disease | 2 | 1976 | 267 |
Why?
| Neoplasms | 2 | 1975 | 239 |
Why?
| Antigens | 1 | 1972 | 66 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1992 | 88 |
Why?
| Cohort Studies | 1 | 1995 | 332 |
Why?
| Virus Replication | 7 | 1972 | 90 |
Why?
| Child, Preschool | 3 | 1979 | 554 |
Why?
| Evaluation Studies as Topic | 4 | 1976 | 178 |
Why?
| Genetic Variation | 1 | 1972 | 91 |
Why?
| Nasopharynx | 2 | 1988 | 27 |
Why?
| Cytoplasm | 1 | 1972 | 108 |
Why?
| Cerebrovascular Disorders | 1 | 1992 | 66 |
Why?
| Immunity, Cellular | 3 | 1977 | 85 |
Why?
| Haemophilus influenzae | 3 | 1981 | 39 |
Why?
| Kidney | 4 | 1972 | 223 |
Why?
| Rabbits | 3 | 1980 | 252 |
Why?
| Ribonucleosides | 2 | 1977 | 8 |
Why?
| Acute Disease | 2 | 1992 | 271 |
Why?
| Cation Transport Proteins | 1 | 2010 | 17 |
Why?
| Pseudomonas Infections | 2 | 1976 | 19 |
Why?
| Headache | 1 | 2010 | 39 |
Why?
| Ribavirin | 2 | 1977 | 23 |
Why?
| Immunoglobulin A, Secretory | 1 | 1990 | 11 |
Why?
| Prognosis | 1 | 1994 | 388 |
Why?
| RNA, Viral | 1 | 1992 | 91 |
Why?
| Skin | 1 | 2012 | 177 |
Why?
| Base Sequence | 2 | 1988 | 371 |
Why?
| Adjuvants, Immunologic | 1 | 2010 | 73 |
Why?
| Staphylococcus aureus | 1 | 2010 | 48 |
Why?
| Haptens | 1 | 1989 | 10 |
Why?
| Fatigue | 1 | 2010 | 48 |
Why?
| Diphtheria Toxin | 1 | 1989 | 13 |
Why?
| Texas | 1 | 2009 | 21 |
Why?
| Placebo Effect | 1 | 2009 | 26 |
Why?
| Molecular Sequence Data | 2 | 1988 | 404 |
Why?
| Liver Transplantation | 2 | 1977 | 54 |
Why?
| Vaccines | 1 | 1989 | 33 |
Why?
| Sensitivity and Specificity | 1 | 1992 | 427 |
Why?
| Viral Core Proteins | 1 | 1988 | 14 |
Why?
| Influenza A Virus, H2N2 Subtype | 1 | 1988 | 3 |
Why?
| Virulence | 3 | 1980 | 48 |
Why?
| Prevalence | 1 | 1990 | 281 |
Why?
| Survival Analysis | 1 | 2010 | 205 |
Why?
| Lipopeptides | 1 | 2007 | 1 |
Why?
| Gluconates | 1 | 1987 | 3 |
Why?
| Anticonvulsants | 1 | 1989 | 61 |
Why?
| Analgesics, Opioid | 1 | 2009 | 37 |
Why?
| Interferon Type I | 1 | 1987 | 22 |
Why?
| Rare Diseases | 1 | 2007 | 15 |
Why?
| Sigmoidoscopy | 1 | 2007 | 14 |
Why?
| Zinc | 1 | 1987 | 37 |
Why?
| Kinetics | 2 | 1980 | 349 |
Why?
| 2-Aminopurine | 1 | 2007 | 4 |
Why?
| Vulvar Diseases | 1 | 2007 | 19 |
Why?
| Protective Devices | 1 | 1986 | 12 |
Why?
| Bromodeoxyuridine | 1 | 2007 | 47 |
Why?
| Valine | 1 | 2007 | 27 |
Why?
| DNA | 1 | 1992 | 262 |
Why?
| Kaplan-Meier Estimate | 1 | 2007 | 89 |
Why?
| RNA-Binding Proteins | 1 | 1988 | 55 |
Why?
| Dose-Response Relationship, Immunologic | 3 | 1977 | 37 |
Why?
| Mutation | 6 | 1976 | 340 |
Why?
| Cell Line | 2 | 1985 | 375 |
Why?
| Leukemia, Erythroblastic, Acute | 1 | 1985 | 15 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 38 |
Why?
| Myocardial Ischemia | 1 | 2007 | 62 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1986 | 32 |
Why?
| Occupational Diseases | 1 | 1986 | 51 |
Why?
| Pregnancy | 2 | 1980 | 455 |
Why?
| Anti-Inflammatory Agents | 1 | 2007 | 80 |
Why?
| Virus Activation | 1 | 2005 | 12 |
Why?
| Analgesics | 1 | 2007 | 47 |
Why?
| Orthomyxoviridae Infections | 2 | 1980 | 29 |
Why?
| Lymphocytes | 1 | 1986 | 142 |
Why?
| Sputum | 1 | 2005 | 26 |
Why?
| Antibody Formation | 4 | 1974 | 89 |
Why?
| Encephalitis | 1 | 1985 | 29 |
Why?
| Amikacin | 1 | 1984 | 5 |
Why?
| Enterobacteriaceae Infections | 1 | 1984 | 5 |
Why?
| Viral Plaque Assay | 2 | 1977 | 18 |
Why?
| Aminoglycosides | 1 | 1984 | 12 |
Why?
| Radioimmunoassay | 1 | 1984 | 81 |
Why?
| Immunologic Memory | 1 | 2005 | 51 |
Why?
| Immunization, Secondary | 4 | 1976 | 31 |
Why?
| Cell Culture Techniques | 1 | 2004 | 74 |
Why?
| Phenotype | 4 | 1980 | 303 |
Why?
| Drug Utilization | 1 | 1984 | 32 |
Why?
| Administration, Oral | 2 | 1987 | 170 |
Why?
| Hospitals, University | 1 | 1984 | 59 |
Why?
| Aspirin | 1 | 1983 | 50 |
Why?
| Vidarabine | 1 | 1982 | 17 |
Why?
| Drug Evaluation | 2 | 1978 | 54 |
Why?
| Fetal Blood | 1 | 1983 | 54 |
Why?
| Graft vs Host Reaction | 1 | 1982 | 4 |
Why?
| Tomography, X-Ray Computed | 1 | 2007 | 321 |
Why?
| Airway Resistance | 1 | 1982 | 15 |
Why?
| Immunization, Passive | 1 | 1982 | 39 |
Why?
| Diabetes Complications | 2 | 1976 | 49 |
Why?
| Adsorption | 1 | 1981 | 36 |
Why?
| Dithiothreitol | 1 | 1981 | 15 |
Why?
| United States | 1 | 1989 | 604 |
Why?
| Cefamandole | 1 | 1981 | 3 |
Why?
| Ampicillin | 1 | 1981 | 16 |
Why?
| Socioeconomic Factors | 1 | 1983 | 144 |
Why?
| Penicillin Resistance | 1 | 1981 | 14 |
Why?
| ABO Blood-Group System | 1 | 1981 | 26 |
Why?
| Haemophilus Infections | 1 | 1981 | 30 |
Why?
| Centrifugation, Isopycnic | 1 | 1980 | 2 |
Why?
| Retinitis | 1 | 1980 | 4 |
Why?
| Immunosorbent Techniques | 1 | 1980 | 22 |
Why?
| Deoxyribonucleases | 1 | 1980 | 11 |
Why?
| Filtration | 1 | 1980 | 27 |
Why?
| Anemia, Hemolytic, Autoimmune | 1 | 1980 | 10 |
Why?
| Polyradiculoneuropathy | 1 | 1980 | 9 |
Why?
| Myocarditis | 1 | 1980 | 10 |
Why?
| Vaccines, Combined | 1 | 1999 | 9 |
Why?
| Oseltamivir | 1 | 1999 | 8 |
Why?
| Diagnosis, Differential | 2 | 1976 | 402 |
Why?
| Cricetinae | 4 | 1975 | 130 |
Why?
| Leukemia | 2 | 1977 | 70 |
Why?
| Hydrolysis | 1 | 1980 | 57 |
Why?
| Area Under Curve | 1 | 1999 | 47 |
Why?
| Colitis, Ulcerative | 1 | 1980 | 21 |
Why?
| Nose | 1 | 1999 | 31 |
Why?
| Sexually Transmitted Diseases | 1 | 1980 | 18 |
Why?
| Phenylenediamines | 1 | 1979 | 3 |
Why?
| Hepatitis B Antibodies | 1 | 1979 | 11 |
Why?
| Hemophilia B | 1 | 1979 | 9 |
Why?
| Colonic Neoplasms | 1 | 1980 | 63 |
Why?
| Maternal-Fetal Exchange | 1 | 1980 | 49 |
Why?
| Hemophilia A | 1 | 1979 | 23 |
Why?
| Herpesvirus 4, Human | 1 | 1979 | 34 |
Why?
| Research Design | 2 | 1975 | 169 |
Why?
| Administration, Intravesical | 1 | 1998 | 17 |
Why?
| Uterine Cervical Neoplasms | 1 | 1980 | 55 |
Why?
| von Willebrand Diseases | 1 | 1979 | 8 |
Why?
| Histoplasmosis | 1 | 1978 | 7 |
Why?
| Injections, Subcutaneous | 2 | 1975 | 63 |
Why?
| Proteinuria | 2 | 1974 | 20 |
Why?
| Scotland | 1 | 1977 | 9 |
Why?
| New Jersey | 1 | 1977 | 6 |
Why?
| Bacterial Capsules | 2 | 1986 | 16 |
Why?
| Creatinine | 2 | 1974 | 69 |
Why?
| England | 1 | 1977 | 20 |
Why?
| Drug Resistance, Multiple | 1 | 1997 | 19 |
Why?
| Leucomycins | 1 | 1976 | 1 |
Why?
| Insects | 1 | 1996 | 11 |
Why?
| Zanamivir | 1 | 1996 | 9 |
Why?
| Pyrans | 1 | 1996 | 11 |
Why?
| Virus Shedding | 1 | 1996 | 8 |
Why?
| Guanidines | 1 | 1996 | 26 |
Why?
| Bacteria | 1 | 1976 | 42 |
Why?
| Transplantation Immunology | 1 | 1975 | 19 |
Why?
| Lymphocytic Choriomeningitis | 1 | 1975 | 2 |
Why?
| Blood Platelets | 2 | 1975 | 67 |
Why?
| Laboratory Infection | 1 | 1975 | 2 |
Why?
| Urticaria | 1 | 1975 | 14 |
Why?
| Bone Marrow Cells | 1 | 1977 | 92 |
Why?
| Patient Admission | 1 | 1995 | 72 |
Why?
| Glomerulonephritis | 1 | 1974 | 20 |
Why?
| Nasal Lavage Fluid | 1 | 1994 | 2 |
Why?
| Pseudomonas aeruginosa | 1 | 1976 | 33 |
Why?
| Population Surveillance | 1 | 1995 | 70 |
Why?
| Prostatic Neoplasms | 1 | 1980 | 120 |
Why?
| Dogs | 1 | 1994 | 159 |
Why?
| Ethanol | 1 | 1974 | 58 |
Why?
| Recombinant Proteins | 1 | 1996 | 290 |
Why?
| Neutrophils | 1 | 1975 | 114 |
Why?
| Antibodies | 1 | 1974 | 159 |
Why?
| Floxuridine | 1 | 1972 | 1 |
Why?
| Canavanine | 1 | 1972 | 4 |
Why?
| Genetics, Microbial | 1 | 1972 | 7 |
Why?
| Angiography, Digital Subtraction | 1 | 1992 | 18 |
Why?
| Dactinomycin | 1 | 1972 | 40 |
Why?
| Cycloheximide | 1 | 1972 | 51 |
Why?
| Immune Sera | 1 | 1972 | 56 |
Why?
| Kidney Diseases | 1 | 1974 | 90 |
Why?
| Viruses | 1 | 1992 | 15 |
Why?
| Gastrointestinal Diseases | 1 | 1972 | 31 |
Why?
| Urine | 1 | 1972 | 35 |
Why?
| Arginine | 1 | 1972 | 57 |
Why?
| Microscopy, Electron | 1 | 1972 | 178 |
Why?
| Respiratory Tract Diseases | 1 | 1972 | 34 |
Why?
| HLA Antigens | 2 | 1981 | 38 |
Why?
| Prednisone | 1 | 1972 | 80 |
Why?
| Saliva | 1 | 1972 | 61 |
Why?
| Histocompatibility Testing | 2 | 1978 | 24 |
Why?
| Carbohydrate Conformation | 1 | 1989 | 8 |
Why?
| Nucleoproteins | 1 | 1988 | 10 |
Why?
| Cell Nucleus | 1 | 1972 | 169 |
Why?
| Viral Matrix Proteins | 1 | 1988 | 12 |
Why?
| Structure-Activity Relationship | 1 | 1989 | 124 |
Why?
| Ferrets | 1 | 1988 | 11 |
Why?
| Mesocricetus | 1 | 1988 | 17 |
Why?
| Tablets | 1 | 1987 | 8 |
Why?
| Eye Protective Devices | 1 | 1986 | 4 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 167 |
Why?
| Hospital Departments | 1 | 1986 | 15 |
Why?
| Periodic Acid | 1 | 1986 | 6 |
Why?
| Homosexuality | 1 | 1986 | 17 |
Why?
| Immunoglobulin Fab Fragments | 1 | 1986 | 23 |
Why?
| Genotype | 1 | 1988 | 175 |
Why?
| HIV | 1 | 1986 | 32 |
Why?
| Histocompatibility Antigens | 1 | 1985 | 17 |
Why?
| Sexual Behavior | 1 | 1986 | 37 |
Why?
| Hepatomegaly | 1 | 1965 | 7 |
Why?
| Splenomegaly | 1 | 1965 | 14 |
Why?
| Virus Cultivation | 1 | 1965 | 24 |
Why?
| Epidemiology | 1 | 1965 | 15 |
Why?
| Liver Function Tests | 1 | 1965 | 25 |
Why?
| Liver Diseases | 1 | 1965 | 56 |
Why?
| Lung | 2 | 1980 | 232 |
Why?
| Amino Acid Sequence | 1 | 1988 | 319 |
Why?
| Respiratory Function Tests | 1 | 1983 | 72 |
Why?
| Aerosols | 1 | 1983 | 39 |
Why?
| Pediatrics | 1 | 1986 | 133 |
Why?
| Chloramphenicol | 1 | 1981 | 13 |
Why?
| Lymphoma | 1 | 1982 | 96 |
Why?
| Mice | 1 | 1972 | 623 |
Why?
| Hospital Bed Capacity, 500 and over | 1 | 1980 | 17 |
Why?
| Central Nervous System | 1 | 1981 | 77 |
Why?
| Herpesviridae Infections | 1 | 1980 | 25 |
Why?
| Xylenes | 1 | 1979 | 5 |
Why?
| Immunization | 1 | 1980 | 85 |
Why?
| Sulfisoxazole | 1 | 1978 | 7 |
Why?
| Skin Manifestations | 1 | 1978 | 6 |
Why?
| Pharyngeal Diseases | 1 | 1978 | 5 |
Why?
| Hemagglutinins | 1 | 1978 | 12 |
Why?
| Mouth Diseases | 1 | 1978 | 19 |
Why?
| Hot Temperature | 1 | 1978 | 93 |
Why?
| Gram-Negative Aerobic Bacteria | 1 | 1976 | 1 |
Why?
| Gram-Negative Anaerobic Bacteria | 1 | 1976 | 1 |
Why?
| Carbenicillin | 1 | 1976 | 2 |
Why?
| Aerobiosis | 1 | 1976 | 14 |
Why?
| Antibodies, Heterophile | 1 | 1976 | 2 |
Why?
| Anaerobiosis | 1 | 1976 | 15 |
Why?
| Administration, Topical | 1 | 1975 | 57 |
Why?
| Cerebrospinal Fluid Proteins | 1 | 1975 | 9 |
Why?
| Convalescence | 1 | 1975 | 15 |
Why?
| Blood Cell Count | 1 | 1975 | 31 |
Why?
| Lymphocytic choriomeningitis virus | 1 | 1975 | 3 |
Why?
| Kidney Function Tests | 1 | 1975 | 24 |
Why?
| L-Lactate Dehydrogenase | 1 | 1975 | 59 |
Why?
| Diabetic Nephropathies | 1 | 1974 | 18 |
Why?
| Nephrotic Syndrome | 1 | 1974 | 16 |
Why?
| Amyloidosis | 1 | 1974 | 31 |
Why?
| Glomerular Filtration Rate | 1 | 1974 | 33 |
Why?
| Liver | 1 | 1979 | 248 |
Why?
| Glucose | 1 | 1975 | 120 |
Why?
|
|
Betts's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
